Company intelligence / Profile preview

Zeta Surgical

Boston, Massachusetts, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Zeta Surgical’s cranial navigation system has completed a successful multicenter clinical trial in Singapore, demonstrating 100% single-pass catheter placement and zero revision surgeries or adverse events in 15 patients undergoing ventriculostomies, compared to historical freehand controls[7]. The system has received FDA 510(k) clearance and is being rolled out in a limited U.S. pilot ahead of a broader launch in 2025[5][6].

Therapeutic areas: OncologyNeurology
Modalities: DeviceRobotic assistance
Industry: Surgical Medical Devices

Partnerships

Brigham and Women’s HospitalMassachusetts General HospitalIZI Medical

Beyond the preview

Go deeper on Zeta Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zeta Surgical.

Explore the full profile